Indeed, the characterization of SCCOHT-1 cells and chemotherapeutic responses has revealed a constitutive expression of NED markers such as NCAM in the original patient tumor and derived mouse xenograft tumors [9,12]. The gene discussed is NCAM1; the disease is neoplasm.